Intermediate Capital Group (ICG) retains Rothschild to sell Suanfarma for up to EUR 250m
Intermediate Capital Group (ICG) habría encargado a Rothschild la venta de Suanfarma por hasta EUR 250m
Intel ID : 323148
|
||||
| Intel ID | 323148 | |||
| Value | EUR 250,00m (Approx.) | |||
| Native Currency | Euro (EUR) | |||
|
Financial Data - Suanfarma
(31 Dec 2022) |
Revenue: EUR 92,43m EBITDA: EUR 1,97m Net Debt: EUR 722,88m People: 31 |
|||
| Date |
 |
|||
| Country |  |
|||
| Geography | |
|||
| Subsector (Old TTR Sectors) |
|
|||
| Type |
|
|||
| Intel Grade |
|
|||
| Source |
|
|||
| Tags | |
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Secondary Sectors (TTRSC) |
30.02.03 Healthcare Product Distributors 30 Healthcare / 30.02 Healthcare Equipment & Supplies |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Seller
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
25.01.09 Private Equity 25 Financial Services / 25.01 Banking & Investment |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Financial Advisory
| Parties | Advisor | Notes from Advisors | |||||
|---|---|---|---|---|---|---|---|
|
|
- |
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.